An investor whose portfolio contains some value- or income-focused investments and some growth-oriented investments, who ...

Learn more about whether Legend Biotech Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a ...

Viking Therapeutics focuses on novel therapies for metabolic disorders, still in clinical trials with no market products. Stock is speculative, depends on successful clinical trials of its lead drug ...

The biotech sector has put up a strong recovery in 2025. The Nasdaq Biotechnology Index has risen 33.1% so far this year. The index bottomed out in April 2025 on potential imposition of steep tariffs, ...

Investing.com -- Trinity Biotech plc (NASDAQ:TRIB) stock surged 81.6% in Tuesday’s premarket trading after the company announced a substantial order for 9 million units of its TrinScreen HIV screening ...